ライフサイエンスコーパス: nonocclusive

1 A), and recombinant scuPA (rscuPA) in lysing nonocclusive 111In-labeled platelet-rich arterial-type t

2 Nonocclusive acute mesenteric ischemia was induced by pe

3 the ratio of mean occlusive divided by mean nonocclusive arterial blood pressure, both subtracted by

4 patients, insignificant residual flows, and nonocclusive asymptomatic stent thrombosis in 4 patients

5 We used a closed-chest pig model of nonocclusive coronary stenosis (n = 14) created by infla

6 erization of achalasia subtypes by detecting nonocclusive esophageal contractions not observed with s

7 FNC set at 40 L/min compared with a standard nonocclusive facial mask at the same clinically set FiO2

8 ardiac perforation/pericardial effusion, one nonocclusive femoral venous thrombus, and one retrieval

9 Nonocclusive fibrin microthrombi (without ischemic injur

10 aphy (OCT) were performed using pullback and nonocclusive flushing techniques.

11 Inhibition by quisqualate and DCG-IV was nonocclusive in neurons responding to both agonists.

12 Also in cardiac tamponade-induced nonocclusive intestinal ischemia, the superior mesenteri

13 ortic aneurysms (AAAs) is the formation of a nonocclusive intraluminal thrombus (ILT) in regions of a

14 A follow-up ultrasound shows nonocclusive intraluminal thrombus in the left superfici

15 should likely be held to similar criteria as nonocclusive lesions.

16 intervention is considerably higher than for nonocclusive lesions.

17 eased SMA blood flow by 60% in this model of nonocclusive mesenteric ischemia (from 168 +/- 41 to 269

18 lete occlusion after four cycles (n = 6), or nonocclusive mesenteric ischemia was induced by pericard

19 The incidence of nonocclusive mesenteric ischemia was particularly high.

20 Urgent laparotomy confirmed extensive nonocclusive mesenteric ischemia, and the patient rapidl

21 r infusion may be an effective treatment for nonocclusive mesenteric ischemia, it has also been advoc

22 tion of P-G6 reduces thrombus formation in a nonocclusive model of deep vein thrombosis with a commen

23 Transiently occlusive (<48 hours) and nonocclusive mural thrombi persisted longer in apoE(-/-)

24 cclusive into the ophthalmic artery [OA] vs. nonocclusive; P < 0.001) were included in multivariate a

25 kg) administered 24 hours before inserting a nonocclusive periarterial carotid collar into New Zealan

26 of thrombosis were found: the formation of a nonocclusive plug, if injury length does not exceed the

27 lood reservoir, a membrane oxygenator, and a nonocclusive roller pump.

28 tion was induced in the animals by placing a nonocclusive silastic collar around the left common caro

29 ed period (e.g., 24 h) based on the use of a nonocclusive style sweat patch adhered to a skin.

30 catheterized leg at 48 hrs revealed a small nonocclusive thrombosis, whereas the opposite leg remain

31 t regulate the balance between occlusive and nonocclusive thrombosis.

32 duces thrombosis within stented aortas where nonocclusive thrombus acts as capacitive space for drug

33 e inflammation, and fibrin deposits on early nonocclusive vascular thrombosis.

34 ulomatous keratic precipitates in 2 eyes and nonocclusive vasculitis in one eye.

35 and right and left portal vein thrombi were nonocclusive, while most (63 of 86) of the segmental vei